Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Alemtuzumab in Patients With Advanced Mycosis Fungoides/Sezary Syndrome

NCT00157274 is registered in ClinicalTrials.gov with Latin American Cooperative Onco-Haematology Group - Peru as lead sponsor.

NCT NCT00157274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00157274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Alemtuzumab in Patients With Advanced Mycosis Fungoides/Sezary Syndrome
Lead sponsor
Latin American Cooperative Onco-Haematology Group - Peru
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2005
Completion date
July 31, 2008
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mycosis fungoides, sezary syndrome